Skip to content

Independent medical information

What Is Morpheus8 (Radiofrequency Microneedling)?

Morpheus8 is a radiofrequency microneedling device that heats the dermis through fine needles. Evidence is best for acne scars; effects on laxity are modest.

Short answer

Morpheus8 is a brand of radiofrequency (RF) microneedling device made by InMode: fine insulated needles enter the skin and release radiofrequency energy, heating the deeper layer of the skin (the dermis) to prompt collagen remodelling. It is mainly used for acne scars, fine lines and mild skin laxity, usually over a short course of sessions. How much it helps depends on the cause and severity of the concern, the skin type, and the settings and training of the person using it. It is a medical procedure, not a cosmetic treatment, and it does not reproduce the effect of surgery.

Key points

  • Morpheus8 is one device within the wider category of radiofrequency microneedling.
  • The best-studied use is acne scarring; evidence for skin tightening is weaker.
  • Two to four sessions are typical, with results building over three to six months.
  • Redness, pinpoint bleeding and swelling are expected; burns, scarring and fat loss have been reported.
  • Darker skin types carry a risk of post-inflammatory hyperpigmentation, and settings need adjusting.

How radiofrequency microneedling works

Plain microneedling makes tiny punctures in the skin to trigger a healing response. Radiofrequency microneedling adds heat: the needles are electrodes that deliver radiofrequency energy under the skin surface, creating small zones of controlled heating.1 Because the needles are insulated along most of their length, the surface layer of skin (the epidermis) is largely spared while the dermis below is heated.3

The heat causes tiny columns of coagulated tissue. As these heal, the skin lays down new collagen and remodels existing fibres, which is the proposed basis for smoother texture and modest firming.3 A review in a plastic surgery journal notes that outcomes depend on placing the energy at the right depth, which varies by facial area, and that needle length alone does not determine where the heat lands.3

Is Morpheus8 different from other RF microneedling devices?

Morpheus8 is a trade name rather than a separate technique. Several manufacturers make radiofrequency microneedling systems, and they differ in needle design, depth range, energy delivery and handpieces. In the United States, the Food and Drug Administration (FDA) treats these as Class II medical devices cleared through its 510(k) route, which assesses equivalence to existing devices rather than proving a cosmetic benefit.1

The FDA clearance for the InMode system with Morpheus8 applicators describes it as intended for dermatologic procedures needing coagulation or contraction of soft tissue, or control of bleeding. The same document limits use at higher energy levels (above 62 millijoules per pin) to skin types I to IV, meaning lighter to medium-brown skin.2 That restriction is a practical reminder that settings must be matched to skin type.

Brand comparisons between devices are rarely tested head to head. For most patients, the operator’s training, the depth and energy chosen, and how well the treatment fits the underlying problem matter more than the device name.

What it is used for, and what the evidence says

Radiofrequency microneedling is used for wrinkles, scars and loss of firmness.4 Reviews also list stretch marks, enlarged pores, and some off-face uses, but the quality of evidence varies a great deal between these indications.3

ConcernEvidenceWhat it suggests
Acne scarsModerateA 2025 systematic review of 16 studies (481 patients) found improvement in all studies, broadly similar to fractional lasers, but with short follow-up and varied scoring.5
Fine lines and wrinklesLimitedMostly small studies and narrative reviews; improvement tends to be modest.3
Skin laxityLimitedSome tightening is reported, but it is not a substitute for surgical lifting.4
Evidence for radiofrequency microneedling by concern. Labels reflect the overall strength of published evidence, not individual results.

Even the acne scar evidence has gaps. The review authors could not pool results statistically because studies used different scoring systems, follow-up lasted no more than six months, and several trials carried some risk of bias.5 Results for one scar type, such as shallow rolling scars, may not apply to deep “ice-pick” scars, which often need other approaches.

Sessions, comfort and recovery

A numbing cream is usually applied first, and a session takes about an hour. Two to four sessions are commonly recommended, and results typically appear gradually over three to six months as collagen forms.4 Discomfort was common in the acne scar studies, so the experience is not pain-free for everyone.5

Afterwards the skin is usually pink for about a day, with tiny spots of bleeding or slight bruising, and many people return to normal activities within a day.4 Higher settings tend to mean more swelling and a longer recovery. Grid-pattern marks from the needle tips can persist for days to weeks, and their presence may lead a clinician to lower the energy at the next session.3

Risks, and why skin type matters

Expected short-term effects include redness, swelling, pinpoint bleeding and mild pain.3 Recognised complications include post-inflammatory hyperpigmentation (darkening of the skin after inflammation), persistent track marks, acne flares and reactivation of cold sores.5

In October 2025 the FDA warned that burns, scarring, fat loss, disfigurement and nerve damage had been reported with radiofrequency microneedling, some needing surgical repair. It stated plainly that the procedure is a medical procedure, not a cosmetic treatment, advised against home use, and recommended treatment by a licensed provider trained in these devices.1 Two US professional societies responded by encouraging members to include these risks in consent forms.6 How often these serious events occur is not known: Uncertain incidence.

Skin type changes the balance. Because the surface is partly spared, radiofrequency microneedling is often considered for darker skin, where some lasers carry a higher pigment risk, and most participants in the acne scar review had skin types III to V.5 However, pigment change remains a concern in darker skin when energy sits too close to the surface or the skin is exposed to sun afterwards.3 No study in that review included the darkest skin type (type VI), so safety there is Insufficient.5

When to seek medical advice

The FDA advises anyone with problems or concerns after radiofrequency microneedling to seek care from a licensed provider.1 Signs that go beyond the expected short-term redness, such as blistering or burn-like areas, a dent or hollowing in the skin, numbness or weakness of facial movement, or worsening pain, should be assessed promptly rather than left to settle.

Common questions

Is Morpheus8 the same as a laser?

No; it uses radiofrequency energy delivered through needles, not light. In acne scar studies it performed broadly similarly to some fractional lasers, but the two have different risk profiles and suit different skin and scar types.5 See what laser skin resurfacing involves.

Can it replace a facelift?

No; it is not a replacement for surgery and will not match surgical results.4 It may suit mild texture or laxity concerns, whereas marked sagging of the jowls or neck reflects deeper changes that energy devices do not correct.

How soon will I see results?

Most change appears gradually over three to six months, because collagen remodelling takes time.4 Early plumpness in the first days is mostly swelling.

Can it be done at home?

No; the FDA specifically advises against using radiofrequency microneedling devices at home.1

Bottom line

Morpheus8 is one branded form of radiofrequency microneedling, with its most consistent evidence in acne scarring and more modest, less certain effects on wrinkles and laxity. Serious injuries are uncommon but documented, so skin type, realistic expectations and the training of the person operating the device deserve as much attention as the brand.

Sources

  1. US Food and Drug Administration. Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling: FDA Safety Communication. FDA; 2025. https://www.fda.gov/medical-devices/safety-communications/potential-risks-certain-uses-radiofrequency-rf-microneedling-fda-safety-communication. Accessed 5 November 2026.
  2. US Food and Drug Administration. 510(k) K231790: The InMode System with the Morpheus8 Applicators. FDA; 2023. https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231790.pdf. Accessed 5 November 2026.
  3. Shauly O, Marxen T, Menon A, Gould DJ, Miller LB, Losken A. Radiofrequency Microneedling: Technology, Devices, and Indications in the Modern Plastic Surgery Practice. Aesthetic Surgery Journal Open Forum; 2023;5:ojad100. https://doi.org/10.1093/asjof/ojad100
  4. Cleveland Clinic. Radio Frequency (RF) Microneedling. Cleveland Clinic. https://my.clevelandclinic.org/cosmetic-plastic-surgery/procedures/radio-frequency-rf-microneedling. Accessed 5 November 2026.
  5. Niaz G, Ajeebi Y, Alshamrani HM, Khalmurad M, Lee K. Fractional Radiofrequency Microneedling as a Monotherapy in Acne Scar Management: A Systematic Review of Current Evidence. Clinical, Cosmetic and Investigational Dermatology; 2025;18:19–29. https://doi.org/10.2147/CCID.S502295
  6. American Society for Laser Medicine and Surgery; American Society for Dermatologic Surgery. FDA Safety Communication on RF Microneedling. ASLMS; 2025. https://www.aslms.org/about-aslms/media-center/news/2025/12/08/fda-safety-communication-on-rf-microneedling. Accessed 5 November 2026.

Article history

  • — First published.